Stepwise prediction of conformational discontinuous B-cell epitopes using the mapitope algorithm

Proteins: Structure, Function and Genetics

Volumn 68, Issue 1, 2007, Pages 294-304

  Bublil, Erez M ^a   Freund, Natalia Tarnovitski ^a   Mayrose, Itay ^a   Penn, Osnat ^a   Roitburd Berman, Anna ^a   Rubinstein, Nimrod D ^a   Pupko, Tal ^a   Gershoni, Jonathan M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibody; Combinatorial phage display peptide library; Computational algorithm; Epitope mapping; Vaccine

Indexed keywords

AMINO ACID; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PEPTIDE; PEPTIDE LIBRARY; TRASTUZUMAB; VACCINE;

ALGORITHM; ARTICLE; B LYMPHOCYTE; CONFORMATION; CRYSTALLIZATION; DRUG DESIGN; EPITOPE MAPPING; MOLECULAR RECOGNITION; PHAGE DISPLAY; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL;

ALGORITHMS; AMINO ACID SEQUENCE; ANTIBODIES; ANTIBODIES, MONOCLONAL; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY;

EID: 34249886331     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21387     Document Type: Article

References (48)

1. Tetin SY, Stroupe SD. Antibodies in diagnostic applications. Curr Pharm Biotechnol 2004;5:9-16.
2. Berger M, Shankar V, Vafai A. Therapeutic applications of monoclonal antibodies. Am J Med Sci 2002;324:14-30.
3. 2a. Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski Freund N, Weiss Y. Epitope mapping. The first step in developing epitope-based vaccines. BioDrugs 2007;21(2):1.
4. Sussman JL, Lin D, Jiang J, Manning NO, Prilusky J, Ritter O, Abola EE. Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr 1998;54 (Part 6, Part 1):1078-1084.
5. Sotriffer CA, Flader W, Winger RH, Rode BM, Liedl KR, Varga JM. Automated docking of ligands to antibodies: methods and applications. Methods 2000;20:280-291.
6. Totrov M, Abagyan R. Detailed ab initio prediction of lysozyme-antibody complex with 1.6 A accuracy. Nat Struct Biol 1994;1:259-263.
7. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 2001;293:1155-1159.
8. Benjamin DC, Perdue SS. Site-directed mutagenesis in epitope mapping. Methods 1996;9:508-515.
9. Enshell-Seijffers D, Smelyanski L, Gershoni JM. The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. Nucleic Acids Res 2001;29:E50-50.
10. Cortese R, Felici F, Galfre G, Luzzago A, Monaci P, Nicosia A. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol 1994;12:262-267.
11. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990;87:6378-6382.
12. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386-390.
13. Zwick MB, Bonnycastle LL, Menendez A, Irving MB, Barbas CF, III, Parren PW, Burton DR, Scott JK. Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12. J Virol 2001;75:6692-6699.
14. Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ. Discovery of high-affinity peptide binders to BLyS by phage display. J Mol Recognit 2005;18:94-102.
15. Schreiber A, Humbert M, Benz A, Dietrich U. 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. J Comput Chem 2005;26:879-887.
16. Enshell-Seijffers D, Denisov D, Groisman B, Smelyanski L, Meyuhas R, Gross G, Denisova G, Gershoni JM. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J Mol Biol 2003;334:87-101.
17. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999;285:2177-2198.
18. Tsodikov OV, Record MT, Jr, Sergeev YV. Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature. J Comput Chem 2002;23:600-609.
19. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374.
20. Riemer AB, Kraml G, Scheiner O, Zielinski CC, Jensen-Jarolim E. Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu-a new method of epitope definition. Mol Immunol 2005;42:1121-1124.
21. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
22. Berthet-Colominas C, Monaco S, Novelli A, Sibai G, Mallet F, Cusack S. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J 1999;18:1124-1136.
23. Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW, Jr, Leahy DJ. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 2003;421:756-760.
24. Bublil EM, Yeger-Azuz S, Gershoni JM. Computational prediction of the cross-reactive neutralizing epitope corresponding to the monoclonal antibody b12 specific for HIV-1 gp120. FASEB J 2006;20:1762-1774.
25. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. The structural basis of ribosome activity in peptide bond synthesis. Science 2000;289:920-930.
26. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 2001;61 (Suppl 2):1-13.
27. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712.
28. McKeage K, Perry CM. Trastuzumab: a review of its use in the treatment of metastatic breast cancer overexpressing HER2. Drugs 2002;62:209-243.
29. Denisova G, Stern B, Raviv D, Zwickel J, Smorodinsky NI, Gershoni JM. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120. AIDS Res Hum Retroviruses 1996;12:901-909.
30. Oleksiewicz MB, Botner A, Toft P, Normann P, Storgaard T. Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes. J Virol 2001;75: 3277-3290.
31. Stern B, Denisova G, Buyaner D, Raviv D, Gershoni JM. Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library. FASEB J 1997;11:147-153.
32. Mayrose I, Shlomi T, Rubinstein ND, Gershoni JM, Ruppin E, Sharan R, Pupko T. A graph-based algorithm for epitope mapping using combinatorial phage-display libraries. Nucleic Acid Research 2007;35(1):69-78.
33. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007;445(7129):732-737.
34. Van Regenmortel MH, Pellequer JL. Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept Res 1994;7:224-228.
35. Dall'Acqua W, Goldman ER, Lin W, Teng C, Tsuchiya D, Li H, Ysern X, Braden BC, Li Y, Smith-Gill SJ, Mariuzza RA. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry 1998;37:7981-7991.
36. Cunningham BC, Wells JA. Comparison of a structural and a functional epitope. J Mol Biol 1993;234:554-563.
37. Rizzuto CD, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998;280:1949-1953.
38. Pantophlet R, Ollmann Saphire E, Poignard P, Parren PW, Wilson IA, Burton DR. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J Virol 2003;77:642-658.
39. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins 2002;47:409-443.
40. Cherfils J, Duquerroy S, Janin J. Protein-protein recognition analyzed by docking simulation. Proteins 1991;11:271-280.
41. Walls PH, Sternberg MJ. New algorithm to model protein-protein recognition based on surface complementarity. Applications to antibody-antigen docking. J Mol Biol 1992;228:277-297.
42. Helmer-Citterich M, Tramontano A. PUZZLE: a new method for automated protein docking based on surface shape complementarity. J Mol Biol 1994;235:1021-1031.
43. Dixon JS. Evaluation of the CASP2 docking section. Proteins 1997;Suppl 1:198-204.
44. Pellequer JL, Westhof E. PREDITOP: a program for antigenicity prediction. J Mol Graph 1993;11:191-202, 204-210.
45. Halperin I, Wolfson H, Nussinov R. SiteLight: binding-site prediction using phage display libraries. Protein Sci 2003;12:1344-1359.
46. Spiegel PC, Jr, Jacquemin M, Saint-Remy JM, Stoddard BL, Pratt KP. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. Blood 2001;98:13-19.
47. Tarnovitski N, Matthews LJ, Sui J, Gershoni JM, Marasco WA. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides. J Mol Biol 2006;359:190-201.
48. Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC. Structural basis of neutralization by a human anti-SARS spike protein antibody, 80R. J Biol Chem 2006;281:34610-34616.